Disability

Century Health and Tessel Biosciences Collaborate to Apply AI-Curated Real World Data to Advance Early Drug Development in COPD

Despite decades of research, many COPD subpopulations remain poorly understood in real-world settings and underserved by existing therapiesUsing AI to…

5 hours ago

Century Health and Tessel Biosciences Collaborate to Apply AI-Curated Real World Data to Advance Early Drug Development in COPD

Despite decades of research, many COPD subpopulations remain poorly understood in real-world settings and underserved by existing therapiesUsing AI to…

5 hours ago

Brainomix AI Technology Reveals Efficacy of Novel Neuroprotective Drug Candidate in Severe Acute Ischemic Stroke Patients

Brainomix 360 Stroke imaging was utilized to improve and standardize the grading of baseline stroke severity, prior to treatment in…

11 hours ago

Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress

-- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in…

1 day ago

Navigate Expands Ecosystem to Address Caregiving and Weight Management with Homethrive and The Mayo Clinic Diet

WEST DES MOINES, Iowa, Dec. 16, 2025 /PRNewswire/ -- Navigate Wellbeing Solutions announced today the expansion of its Partner Ecosystem, strengthening…

2 days ago

Navigate Expands Ecosystem to Address Caregiving and Weight Management with Homethrive and The Mayo Clinic Diet

WEST DES MOINES, Iowa, Dec. 16, 2025 /PRNewswire/ -- Navigate Wellbeing Solutions announced today the expansion of its Partner Ecosystem, strengthening…

2 days ago

Apyron Pioneering Next Generation Pain Management Solutions

Atlanta, Georgia--(Newsfile Corp. - December 15, 2025) - Apyron, Inc. is a medical technology company with a product portfolio designed…

3 days ago

Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics

GENEVA, SWITZERLAND / ACCESS Newswire / December 15, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX) (MindMaze Therapeutics or the Company)…

4 days ago

InnoCare Announces Approval of the Next-Generation TRK Inhibitor Zurletrectinib in China

BEIJING, Dec. 11, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, announced today that…

1 week ago

Careverse Launches Crowdfunding Campaign, Empowering Every Care Provider with Their Own Private AI Agent

Crowd-backed raise on Wefunder invites providers to join as users and co-owners of an AI-powered "care ecosystem," giving them back…

1 week ago